High peptide purity is essential for reproducible research results, and ≥98% has become the industry standard for most research applications. This purity level ensures that experimental outcomes are attributable to the peptide of interest rather than to impurities that may confound results.
Impurities in peptide preparations can arise from several sources including truncated sequences, deletion sequences, and side products from synthesis. Even minor impurities can have significant effects in sensitive assays. For example, in cell-based assays, impurities may cause cytotoxicity or activate signaling pathways, leading to false-positive or false-negative results. In animal studies, impurities may cause off-target effects that complicate interpretation.
The ≥98% purity standard represents a balance between quality and cost. Achieving higher purity levels (≥99% or ≥99.5%) requires additional purification steps that increase cost and reduce yield. For most research applications, ≥98% provides sufficient purity for reproducible results without excessive cost.
Certain applications require higher purity levels. Structural studies using NMR or X-ray crystallography typically require ≥99% purity. In vivo studies and clinical applications require GMP-grade material with rigorous impurity characterization. Assays requiring absolute quantification may also benefit from higher purity.
At PeptideHub, our standard purification process targets ≥98% purity by RP-HPLC, with optional higher purity (≥99%) available for demanding applications. We provide comprehensive analytical data with every shipment, allowing you to verify purity and identity before use. Our commitment to quality ensures that you receive peptides that meet the highest standards for research applications.